Top Stock Picks from Analysts

Ergebnisse

16

1 neu

Companies which are more than 50% undervalued based on analyst price target.

16 Unternehmen

	Unternehmen	Letzter Preis	7D Rückkehr	1J Rückkehr	Marktkapitalisierung	Analysten Ziel	Bewertung	Wachstum	Div. Rendite	Industrie
	HUBN Neu	CHF 166.60	-5.1%	52.0%	CHF 3.1b	CHF 261.50	42.2	37.2%	1.2%	Capital Goods
	NEAG	CHF 31.10	2.6%	-3.4%	CHF 1.0b	CHF 60.00	6.7	-14.1%	2.9%	Utilities
	CMHC	CHF 56.70	-2.6%	-7.8%	CHF 974.7m	CHF 122.57	10.1	55.1%	3.5%	Pharmaceuticals & Biotech
	KURN	CHF 21.24	-6.0%	-16.0%	CHF 842.6m	CHF 33.92	117.5	58.6%	n/a	Pharmaceuticals & Biotech
	MEDX	CHF 8.91	-0.9%	-16.7%	CHF 362.7m	CHF 14.97	3626.9	64.6%	1.1%	Healthcare
	MIKN	CHF 16.50	1.5%	-10.8%	CHF 275.3m	CHF 29.80	9.8	-1.0%	3.6%	Capital Goods
	PEAN	CHF 4.58	-3.0%	-34.0%	CHF 254.8m	CHF 7.87	1.9	104.4%	0%	Real Estate Management and Development
	NWRN	CHF 12.22	-5.7%	37.6%	CHF 254.2m	CHF 47.48	14.2	50.2%	n/a	Pharmaceuticals & Biotech
	SANN	CHF 15.66	-7.7%	13.3%	CHF 238.8m	CHF 27.50	3.1	18.6%	n/a	Pharmaceuticals & Biotech
	BIOV	CHF 25.30	0.8%	-6.6%	CHF 148.4m	CHF 58.26	46.7	-14.2%	n/a	Pharmaceuticals & Biotech
	MOLN	CHF 3.60	3.4%	21.0%	CHF 137.9m	CHF 9.00	2.4	4.9%	n/a	Pharmaceuticals & Biotech
	VARN	CHF 13.30	0.8%	-30.0%	CHF 134.7m	CHF 25.18	1.5	7.0%	0%	Real Estate Management and Development
	LMN	CHF 11.95	-2.8%	-20.1%	CHF 126.8m	CHF 19.37	41.0	60.9%	3.2%	Consumer Services
	XLS	CHF 14.40	-6.2%	-33.0%	CHF 82.1m	CHF 31.00	298.3	-6.9%	n/a	Pharmaceuticals & Biotech
	MMTX	CHF 0.16	-25.3%	n/a	CHF 23.8m	CHF 2.73	37.0	87.7%	n/a	Pharmaceuticals & Biotech
	ASWN	CHF 0.60	2.6%	-44.4%	CHF 8.7m	CHF 2.00	0.5	83.7%	n/a	Media

Page 1 of 1